Literature DB >> 25440291

Safe management of a bipolar depressed patient with prefrontal repetitive transcranial magnetic stimulation (rTMS) Over 7 years and >2 million stimuli.

Xingbao Li1, Leah Fryml2, Julia Jaskwich Rodriguez2, Joseph Taylor2, Jeff J Borckardt2, Baron Short2, Greg Sahlem2, Donna Roberts2, Mark S George3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25440291      PMCID： PMC8284842          DOI： 10.1016/j.brs.2014.09.005

Source DB:  PubMed          Journal:  Brain Stimul        ISSN： 1876-4754            Impact factor:   8.955


× No keyword cloud information.
  7 in total

1.  Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression?

Authors:  Xingbao Li; Ziad Nahas; Berry Anderson; F Andrew Kozel; Mark S George
Journal:  Depress Anxiety       Date:  2004       Impact factor: 6.505

2.  Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.

Authors:  Mark S George; Sarah H Lisanby; David Avery; William M McDonald; Valerie Durkalski; Martina Pavlicova; Berry Anderson; Ziad Nahas; Peter Bulow; Paul Zarkowski; Paul E Holtzheimer; Theresa Schwartz; Harold A Sackeim
Journal:  Arch Gen Psychiatry       Date:  2010-05

3.  Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting.

Authors:  Dakota Hadley; Berry S Anderson; Jeffrey J Borckardt; Ashley Arana; Xingbao Li; Ziad Nahas; Mark S George
Journal:  J ECT       Date:  2011-03       Impact factor: 3.635

4.  Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.

Authors:  Antonio Mantovani; Martina Pavlicova; David Avery; Ziad Nahas; William M McDonald; Chandra D Wajdik; Paul E Holtzheimer; Mark S George; Harold A Sackeim; Sarah H Lisanby
Journal:  Depress Anxiety       Date:  2012-06-11       Impact factor: 6.505

5.  Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.

Authors:  Linda L Carpenter; Philip G Janicak; Scott T Aaronson; Terrence Boyadjis; David G Brock; Ian A Cook; David L Dunner; Karl Lanocha; H Brent Solvason; Mark A Demitrack
Journal:  Depress Anxiety       Date:  2012-06-11       Impact factor: 6.505

6.  Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.

Authors:  Philip G Janicak; Ziad Nahas; Sarah H Lisanby; H Brent Solvason; Shirlene M Sampson; William M McDonald; Lauren B Marangell; Peter Rosenquist; W Vaughn McCall; James Kimball; John P O'Reardon; Colleen Loo; Mustafa H Husain; Andrew Krystal; William Gilmer; Sheila M Dowd; Mark A Demitrack; Alan F Schatzberg
Journal:  Brain Stimul       Date:  2010-08-11       Impact factor: 8.955

Review 7.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.

Authors:  Simone Rossi; Mark Hallett; Paolo M Rossini; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2009-10-14       Impact factor: 3.708
  7 in total
  2 in total

Review 1.  The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder.

Authors:  Tarique Perera; Mark S George; Geoffrey Grammer; Philip G Janicak; Alvaro Pascual-Leone; Theodore S Wirecki
Journal:  Brain Stimul       Date:  2016-03-16       Impact factor: 8.955

Review 2.  Repetitive Transcranial Magnetic Stimulation in the Treatment of Bipolar Disorder.

Authors:  Danielle Hett; Steven Marwaha
Journal:  Ther Adv Psychopharmacol       Date:  2020-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.